Edito

Following two decades of financial support by Eltem and then the transborder Interreg programs, the review of Neurex activities is quite remarkable. Hundreds of scientific meetings and workshops, controversy debates and lab tours have contributed in the training of junior and senior researchers of the Universities of Basel (CH), Freiburg i.Br. (D) and Strasbourg (F). The creation of a website and a newsletter further participated in reinforcing interactions between French, German and Swiss teams. Bridges were built between fundamental and clinical research by involving clinicians in Neurex activities, while large pharmas or smaller companies interested in neuroscience joined us, broadening the range of themes addressed in our trainings. Further actions have marked out our road such as support to start ups, to publications or for supporting junior PIs coming back from abroad in order to set up their research team in the Upper Rhine Valley. All of this was possible thanks to the involvement of the scientific board and administrative team who wrote this story out of the successive Interreg chapters dedicated to specific aims.

The middle of 2023 marks the end of the Interreg projects. The network is entering a fund-raising phase, which is necessary for its survival and, more generally, for the maintenance of the wonderful trinational dynamic that has been the neuroscience field for over 20 years. There are still many challenges ahead, and we hope to succeed. Whatever the outcome, we would like to thank all those who have contributed, often on a voluntary basis, to the dynamism and success of our network. Have a great summer 2023!

PP